Michael represents organizations and individuals in a wide variety of investigations and enforcement proceedings brought by federal, state and foreign government agencies. His practice focuses on white collar criminal, civil and administrative matters involving the regulation of the health care industry, FDA regulation of medical device companies and pharmaceutical manufacturers, securities enforcement, investment adviser regulation, the U.S. Foreign Corrupt Practices Act, export and trade regulation, public corruption and campaign finance law. Michael has defended numerous cases brought under the U.S. Civil False Claims Act, litigating these cases successfully in federal district court and the federal courts of appeals. Michael also uses his extensive experience defending organizations to assist clients with the design and implementation of compliance systems that help prevent violations of law.
Prior to joining the firm, Michael was a federal prosecutor in the Public Integrity Section of the Criminal Division of the U.S. Department of Justice, where he was responsible for grand jury investigations and prosecutions involving extortion, bribery, conflict of interest, and other offenses committed by public officials. During his tenure at the Public Integrity Section, Michael also conducted preliminary investigations of high-ranking federal officials to determine whether the Attorney General should request the appointment of an Independent Counsel. Michael joined the Department of Justice under the Attorney General’s Honors Program.
Michael has served as co-leader of the firm’s Government Enforcement Practice Group.
Lead counsel for a national health care services provider in a multi-district federal criminal investigation and parallel Civil False Claims Act actions arising from allegations of illegal relationships with hospitals and physicians.
Lead counsel for numerous academic medical centers and faculty physician organizations in a nationwide federal investigation into billing by teaching physicians.
Lead counsel for a U.S. aerospace parts manufacturer in a federal criminal investigation, a parallel Department of Commerce enforcement proceeding and a federal debarment proceeding arising from the alleged unlicensed export of goods to Iran.
As lead counsel for a publicly traded biomanufacturing company, conducted an internal investigation for the board of directors into possible violations of the U.S. Foreign Corrupt Practices Act and successfully managed a voluntary disclosure to the U.S. Securities and Exchange Commission resulting in no enforcement proceeding, sanctions or penalties.
Lead counsel for an academic medical center in a federal criminal investigation into alleged illegal relationships with a major pharmaceutical manufacturer.
Lead counsel for an investment adviser in parallel investigations and enforcement proceedings conducted by the U.S. Securities and Exchange Commission and the U.K.’s Financial Services Authority.
Lead counsel for a major medical device manufacturer in a federal criminal investigation and parallel congressional and state investigations into the company’s marketing practices and relationships with physician consultants.
Lead counsel for the CEO of a medical device manufacturer in a federal criminal investigation of various FDA and other violations by the company.
Lead counsel for a company accused of conducting a scheme to furnish illegal campaign contributions to a candidate for political office.
As lead counsel for a hospital system, achieved the only dismissal in the country of a Civil False Claims Act case brought against numerous hospitals throughout the United States alleging improper inpatient billing for pneumonia.